Pharmacotherapy of anxiety disorders is expanding to novel products. Despite trying other
psychological therapies for anxiety disorders, most therapies were comparable to but not …

Background: Growing numbers of people are using psychedelics for personal
psychotherapy outside clinical settings, but research on such use is scarce. Aims: This study …

Abstract With the Food and Drug Administration designation in 2017 of 3, 4-
methylenedioxymethamphetamine (MDMA) as a breakthrough therapy in post-traumatic …

A variety of classic psychedelics and MDMA have been shown to enhance fear extinction in
rodent models. This has translational significance because a standard treatment for post …

Background: Posttraumatic stress disorder (PTSD) and depression are highly comorbid.
Psilocybin exerts substantial therapeutic effects on depression by promoting neuroplasticity …

Post-traumatic stress disorder (PTSD) is a mental health condition that can occur following
exposure to a traumatic experience. An estimated 12 million US adults are presently affected …

Background Persons with schizophrenia are excluded from psychedelic-assisted therapy
due to concerns about the risk of triggering or worsening psychosis. However, there is …

Psilocybe cubensis is a species of psilocybin mushroom (magic mushroom) of moderate
potency whose principal active compounds are psilocybin and psilocin. Recent studies have …

Psilocybin, a psychoactive substance, has recently garnered attention for its high therapeutic
potential in psychiatry. In this study, we investigated the multifaceted aspects of psilocybin …

The ever-increasing burden of psychiatric disorders and limitations of current treatments
have fueled enormous interest in the therapeutic potential of psychedelics. Yet how …